The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for ...

A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV ...

Brosius and his co-conspirators were notified of the false documentation accompanying these drugs but continued purchasing the steeply discounted HIV drugs and reselling them to pharmacy customers ...

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

Real-world data indicated ART with DTG+3TC was effective and well tolerated among patients with HIV infection regardless of prior ART exposure.

The National Human Rights Commission and the National Agency for the Control of AIDS have called for the local production of HIV/AIDS kits and medications to address the funding shortfall in the ...

Ohlsen said those most at risk for HIV infection are men who have sex with men, people who inject drugs, and anyone who has sex with someone with undiagnosed or untreated HIV. Ohlsen said the ...

According to the data, over two million people are currently living with HIV across Nigeria, highlighting the need for sustained efforts in prevention, testing, and access to treatment.

Brett Giroir, who served as assistant secretary for health, wrote in a post on LinkedIn that making progress on the HIV epidemic in the U.S. was one of his first goals when he assumed his new role ...

Long-acting injectable HIV treatment leads to rectal shedding in a small proportion of patients with HIV, independent of the oral lead-in phase.

Summer is creeping closer, and for Gilead Sciences that only means one thing: the much-anticipated launch of long-acting HIV ...

A 10-year-old girl who'll keep going to the local clinic for the medications to suppress the HIV virus — forgetting that it's now closed. A house painter who no longer has the strength to do his ...